Last reviewed · How we verify
NCT06222346
Online Peer Support in Long-term Conditions
NA trial testing CommonGround in Long-term Physical Health Conditions in 126 participants. Completed in 3 December 2024.
30 October 2024
Quick facts
| Lead sponsor | King's College London |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 126 |
| Start date | 12 February 2024 |
| Primary completion | 30 October 2024 |
| Estimated completion | 3 December 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- CommonGround
- NHS Mental Health
Conditions studied
- Long-term Physical Health Conditions — all drugs for Long-term Physical Health Conditions →
- Subthreshold Depression — all drugs for Subthreshold Depression →
Sponsor
King's College London
Who can join
18 and older, any sex, with Long-term Physical Health Conditions or Subthreshold Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Over 15 million people in England live with a long-term physical health condition. Low mood, loneliness and worry related to chronic illness are very common. In partnership with people with long-term conditions we have co-designed an online peer support platform to help people with health problems connect, support others, share experiences, and receive evidence-based information and advice on self-management. This study explores if the platform is feasible to implement and acceptable for people with long-term conditions experiencing mild depressive symptoms. Those allocated to the intervention arm will be invited to try out an online peer support platform with psychoeducational resources named "CommonGround". Those in the control arm will be guided to use the National Health Service NHS "Mental Health" webpages.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Insights and Recommendations From Moderators and Community Members for Keeping Online Peer Support Safe: Thematic Analysis.
Jones HG, Lavelle G, Aylwin-Foster E, Regan C, et al · · 2026 · PMID 41819126 · DOI 10.2196/81943 -
Online Peer Support for Long-Term Conditions: Protocol for a Feasibility Randomized Controlled Trial.
Lavelle G, Jones HG, Carr E, Aylwin-Foster E, et al · · 2025 · PMID 40700748 · DOI 10.2196/71513
Verify or expand the search:
- PubMed search for NCT06222346
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other King's College London trials
Trials by the same sponsor.
- NCT07357064 — Professional Decision Making in Childbirth. · not yet recruiting
- NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
- NCT07228962 — Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies · not yet recruiting
- NCT07365722 — Comparison of Two Non-surgical Procedure to Manage Gum Disease Around Implants. · NA · not yet recruiting
- NCT07378488 — Dance/Movement Therapy for Functional Neurological Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06222346 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King's College London
- Last refreshed: 14 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06222346.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing